Friedman, Mitchell; Hilleman, Daniel E. - In: PharmacoEconomics 19 (2001) 3, pp. 245-254
The incidence, morbidity and mortality of chronic obstructive pulmonary disease (COPD) is rising throughout the world. The total economic cost of COPD in the US in 1993 was estimated to be over $US15.5 billion, with $US6.1 billion for hospitalisation, $US4.4 billion for physician and other fees,...